drugset / Trial / NCT06014853
A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of SOL-804 in Healthy Male Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
Study Design : A randomized, open-label, four-sequence, four-period, crossover, single dosing, phase 1 study
Timeline
- Start
- 2023-08-10
- Primary completion
- 2023-10-28
- Completion
- 2023-11-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Abiraterone acetate | Small molecule | 1000 mg | Oral |
| Subject | SOL-804-F | Unknown | 181.5 mg | Oral |
| Subject | SOL-804-F | Unknown | 242 mg | Oral |
| Subject | SOL-804-F | Unknown | 302.5 mg | Oral |